Psychiatric Mental Health Nurse Practitioner

Running head: PSYCHIATRIC MENTAL HEALTH NURSE PRACTITIONER

Psychiatric Mental Health Nurse Practitioner

Author's Name

Institutional Affiliation

PSYCHIATRIC MENTAL HEALTH NURSE PRACTITIONER

A Psychiatric Mental Health Nurse Practitioner (PMHNP) is a specialized nurse practitioner who

provides mental health care to patients across the lifespan, including children, adolescents,

adults, and older adults. PMHNPs are trained to assess, diagnose, and treat mental health

conditions, including mood disorders, anxiety disorders, psychotic disorders, substance use

disorders, and more.

health nursing. After completing their education, they must pass a national certification exam to

become a certified PMHNP.

Once certified, PMHNPs can work independently or as part of a healthcare team. They may also

choose to specialize in a particular area of mental health, such as child and adolescent psychiatry

or geriatric psychiatry.

PMHNPs have a unique skill set that allows them to provide holistic care to their patients. They

are trained to understand the complex interactions between physical, psychological, and social

factors that contribute to mental health conditions. They also have a deep understanding of how

medications can affect a patient's mental health and overall well-being.

PSYCHIATRIC MENTAL HEALTH NURSE PRACTITIONER

PMHNPs play an essential role in providing mental health care to underserved populations. In

many areas, there is a shortage of mental health professionals, and PMHNPs can help bridge this

gap by providing quality care to patients in need.

In summary, PMHNPs are highly trained healthcare professionals who specialize in providing

PSYCHIATRIC MENTAL HEALTH NURSE PRACTITIONER

professional nursing by an individual who is licensed as a registered nurse and who has

completed additional graduate-level education in a specialized area of nursing. PMHNPs are

included in this definition of APRNs.

In Florida, PMHNPs are licensed Advanced Practice Registered Nurses (APRNs) who are authorized to

provide psychiatric and mental health care services to patients. According to the Florida Board of

Nursing, PMHNPs are allowed to perform the following duties:

1. Conduct assessments and evaluations of patients' mental health status

2. Order and interpret diagnostic tests

3. Develop and implement treatment plans, including medication management and psychotherapy

4. Prescribe medication within their scope of practice

PSYCHIATRIC MENTAL HEALTH NURSE PRACTITIONER

information.

In addition to the general scope of practice for PMHNPs, there are specific regulations and requirements

that they must adhere to in Florida. For example, PMHNPs in Florida must obtain a DEA registration

number to prescribe controlled substances. They must also comply with Florida laws regarding informed

consent, medical records, and confidentiality.

Furthermore, PMHNPs in Florida are required to practice under the supervision of a licensed physician,

either in person or through telehealth services, for the first two years after initial licensure. After this

period, they may continue to practice independently or under the supervision of a physician, depending

on their preference and the requirements of their employer.

In Florida, PMHNPs play an important role in providing psychiatric and mental health care services to

PSYCHIATRIC MENTAL HEALTH NURSE PRACTITIONER

According to the Florida Board of Nursing, PMHNPs are authorized to provide a range of

psychiatric and mental health services, including but not limited to:

1. Conducting comprehensive psychiatric evaluations and assessments

2. Diagnosing and treating mental health disorders

3. Prescribing medications, including controlled substances, in accordance with state and

federal laws and regulations

4. Providing psychotherapy and counseling services

5. Ordering and interpreting diagnostic tests and laboratory work

6. Referring patients to other healthcare providers as needed

PMHNPs must hold a valid Florida RN license and APRN certificate, as well as meet additional

PSYCHIATRIC MENTAL HEALTH NURSE PRACTITIONER

According to Registered Nursing (2019), a psychiatric mental health nurse practitioner

(PMHNPs) is an "advanced practice registered nurse who provide comprehensive mental health

care to patients suffering from behavioral problems and mental health disorders." In the state of

Florida, the PMHNP program seeks to educate APNs who can demonstrate effective decision-

making skills and critical thinking in providing care to individuals and families suffering from

mental health issues. PMHNPs are also responsible for managing the direct care of patients

experiencing chronic health problems.

families in psychiatric as well as primary care settings. However, I would wish to see a number

of changes that I believe can prepare and empower PMHNPs to better treat psychiatric-mental

health problems. For instance, there is a need for the program to begin preparing students to

further their studies, especially at the Doctoral level. Early preparation helps PMHNPs to easily

transition from one level of education to the other. The second change that I would wish to see

implemented in Florida is increased focus on the integration of medical and psychiatric care.

Right from the learning institutions, PMHNPs should be trained on how to better integrate

medical and psychiatric care in order to enable them increases recovery rates, provide more

evidence-based physical health, and reduces overall health care costs.

PSYCHIATRIC MENTAL HEALTH NURSE PRACTITIONER

Do you see any role for advocacy in your state and what would you like to do?

maintaining communication network and education/information resources, and promoting health

PSYCHIATRIC MENTAL HEALTH NURSE PRACTITIONER

References

PSYCHIATRIC MENTAL HEALTH NURSE PRACTITIONER



PSYCHIATRIC MENTAL HEALTH NURSE PRACTITIONER

One area that has piqued my interest in the last few years has been optogenetics.

Optogenetics is a field of science that combines techniques from optics and genetics to control the

activity of specific cells in living tissue using light. This technique involves genetically modifying cells to

activity in specific regions of the brain.

However, optogenetics is still a relatively new technique and there are challenges to its implementation,

such as optimizing the expression and function of opsins, developing safe and effective methods for

delivering light to deep brain structures, and understanding the complex interactions between neural

circuits.

Despite these challenges, optogenetics has already had a significant impact on our understanding of

brain function and has led to important discoveries in fields such as sensory processing, learning and

memory, and neuropsychiatric disorders.

One example of how optogenetics has been used in neuroscience research is in the study of addiction.

Researchers have used optogenetics to selectively activate or inhibit specific neural circuits involved in

In addition to its applications in neuroscience research, optogenetics has also been used in other fields

such as synthetic biology, where it has been used to control gene expression and cellular signaling in

response to light.

Overall, optogenetics has the potential to revolutionize our understanding of brain function and to lead

to new treatments for neurological and psychiatric disorders. However, much more research is needed

to fully understand the complexities of neural circuits and to develop safe and effective ontogenetic

therapies.

PSYCHIATRIC MENTAL HEALTH NURSE PRACTITIONER

potential for unintended effects on non-targeted cells or circuits. Another concern is the potential for

the misuse of optogenetic technology, such as its use in controlling human behavior.

To address these concerns, researchers using optogenetics are required to follow strict safety protocols

and ethical guidelines. They must also be transparent about their methods and results to ensure that

the potential risks and benefits of optogenetics are fully understood by the scientific community and the

Despite these challenges, optogenetics has already had a significant impact on neuroscience and is likely

to continue to be an important tool in both research and potential therapies for neurological and

treatments for brain disorders.

larger animals, making it a promising tool for therapeutic applications.

advancement in the field, as it would allow for more naturalistic behavior studies and could lead to new

therapeutic applications for disorders such as Parkinson's disease and chronic pain.

In summary, optogenetics is a powerful tool that has revolutionized our understanding of brain function

and has the potential to lead to new treatments for neurological and psychiatric disorders. While there

are still challenges to be addressed, ongoing research in optogenetics and related fields is likely to lead

to further breakthroughs and advancements in the field.

Another area of research where optogenetics has been applied is in the study of the gut-brain axis,

which is the bidirectional communication between the gastrointestinal tract and the central nervous

system. Researchers have used optogenetics to study the neural circuits that regulate gastrointestinal

motility and secretion, as well as to investigate the role of gut microbiota in modulating brain function.

Nonetheless, the promise of optogenetics is exciting, and ongoing research in this area is likely to lead to

PSYCHIATRIC MENTAL HEALTH NURSE PRACTITIONER

types or tissues.

blindness, Parkinson's disease, and chronic pain. In these studies, opsins are genetically delivered to

target cells, allowing for the activation or inhibition of specific neural circuits with light. This approach

has the potential to overcome many of the limitations of traditional gene therapy, such as non-specific

In addition to its potential for treating diseases, optogenetic gene therapy also has applications in basic

research. Researchers are using this approach to study the function of specific genes and to investigate

Overall, optogenetic gene therapy represents a promising new approach to treating a wide range of

diseases, and ongoing research in this area is likely to lead to many new discoveries and advancements

optogenetics is likely to lead to many new discoveries and advancements in the coming years, and has

neuroscientist Karl Deisseroth published a paper on the effects of light on the brain. The inspiration for

his experiments came from a German research team, who in 2003 announced the discovery of a new

microbial opsin made from a type of green algae that grows in ponds. When introduced into human

kidney cells, the team discovered that the opsin made the cells respond to flashes of blue light. In the

summer of 2004, Deisseroth and his team, which included Feng Zhang and Ed Boyden, began running

PSYCHIATRIC MENTAL HEALTH NURSE PRACTITIONER

created the world's first reliable technology for creating light-sensitive neurons that signaled at the

speed of the brain” (Boone, 2018).

The field of Optogenetics is broad and although my interest lies in how it may benefit mental health,

it also shows promise of helping other areas, such as infectious disease and neurology. According to

Choy et. al. (2017), “the recent development of optogenetics, because of its unprecedented precision

mediating seizures as well as in the development of epilepsy” (Choy et. al., 2017). According to Arroyo-

chemicals, i.e., poor diffusion, premature degradation, constant activation, and pleiotropic effects; (c)

gene-encoded expression, thus inheritable to the progeny and uniform response in a clonal population”

(Arroyo-Olarte, 2018)

Arroyo-Olarte (2018) further goes on to point out that not all aspects of this new science are

beneficial to the brain. “Just as with any technology, there are credible issues varying from model to

model. These include the general toxicity of light-responsive proteins, basal (dark) activity in regular

cultures, and sensitivity of some organisms to a particular spectrum or intensity of light” (Arroyo-Olarte,

2018). More information on this topic is emerging, it is still a developing area of interest in brain

research. Right now, there are few published peer review articles out there on the topic. I found the

Regis search engine to be helpful to find some articles that speak to the general topic of optogenetics,

pathogen-host intimacy through optogenetics.Plos Pathogens,14(7),

e1007046.https://doi.org/10.1371/journal.ppat.1007046

Boone, L. (2018). Optogenetics.Salem Press Encyclopedia of Health. Retrieved

fromhttps://search.ebscohost.com/login.aspx?

direct=true&db=ers&AN=129815271&site=eds-live

Choy, M., Duffy, B. A., & Lee, J. H. (2017). Optogenetic study of networks in

epilepsy.Journal Of Neuroscience Research,95(12),2325–

2335.https://doi.org/10.1002/jnr.23767

PSYCHIATRIC MENTAL HEALTH NURSE PRACTITIONER

PSYCHIATRIC MENTAL HEALTH NURSE PRACTITIONER

Post 2:

An area of interest to explore further about psychiatric nursing practice is use the use of N-

there is an increasing amount of evidence that NAC can influence the pathophysiological processes

progressive myolonic epilepsy (Deepmala et al., 2015). NAC plays a key role in antioxidant activity

and in the regulation of the glutamatergic system, both of which have implications in either

psychiatric disorder or addiction (Sansone & Sansone, 2011). Of particular interest, is the use of

NAC in the pediatric population given some parents’ understandable hesitancy in giving

psychotropics to their children. Several studies indicate that NAC has been successful in reducing

symptoms of certain disorders such as autism (Dean et al., 2019) in children, and in improving

compulsions associated with obsessive compulsive disorder (Ghanizadeh et al., 2017).

 The most helpful resources on this topic were published studies within the past five years,

several which are cited below. This author did not find any resources that were unhelpful per se, but

it was difficult to find a recommended dosage for use of NAC in the pediatric population. Dosages

Dean, O. M., Gray, K., Dodd, S., Villagonzalo, K., Brown, E., Tonge, B., . . . Byrne, L. K. (2018).

Does N-acetylcysteine improve behaviour in children with autism?: A mixed-methods analysis of the

effects of N-acetylcysteine. Journal of Intellectual & Developmental Disability, , 1-7.

doi:10.3109/13668250.2017.1413079Top of FormBottom of Form

Deepmala, Slattery, J., Kumar, N., Delhey, L., Berk, M., Dean, O., . . . Frye, R. (2015). Clinical trials

of N-acetylcysteine in psychiatry and neurology: A systematic review. Neuroscience & Biobehavioral

Reviews, 55, 294-321. doi://doi.org/10.1016/j.neubiorev.2015.04.015

Ghanizadeh, A., Mohammadi, M. R., Bahraini, S., Keshavarzi, Z., Firoozabadi, A., & Alavi Shoshtari,

A. (2017). Efficacy of n-acetylcysteine augmentation on obsessive compulsive disorder: A

PSYCHIATRIC MENTAL HEALTH NURSE PRACTITIONER

new era of potent and targeted control over multiple aspects of neural function. Genetic and

optical methods applied together allow tight spatial and temporal control of the activity of

specific kinds of neurons in the living brain, a revolutionary advance that will allow us to

achieve an unprecedented understanding of neural circuit function in behaving animals. In brief,

neurons are first genetically engineered (using a variety of mechanisms, described later) to

express light-sensitive proteins (opsins). When these neurons are then illuminated with light of

the correct frequency they will be transiently activated or inhibited or their signaling pathways

will be modulated, depending on the particular kind of opsin that was chosen for expression. Cell

type–specific expression is typically achieved with transgenic animals, viral vectors, or a

combination, and spatially restricted light application allows for further refinement in targeting

activity within the cell, control of multiple neural channels in parallel, and, most recently, control

of neural activity in parallel with optical monitoring of neural activity (Bamann et al., 2013).

References:

1. Boyden ES, Zhang F, Bamberg E, Nagel G, Deisseroth K. (2015)BMillisecond-timescale,

genetically targeted optical control of neural activity.BNat NeurosciB8:1263–1268

2. Bamann C, Gueta R, Kleinlogel S, Nagel G, Bamberg E. (2013)BStructural guidance of

the photocycle of channelrhodopsin-2 by an interhelical hydrogen

bond.BBiochemistryB49:267–278.

PSYCHIATRIC MENTAL HEALTH NURSE PRACTITIONER

I like your topic about the use of N-acetylcysteine (NAC) in patients with a psychiatric disorder.

N-acetylcysteine, a sulphur-containing amino acid for the treatment of paracetamol overdose and

psychiatric conditions. This narrative review synthesises and presents the current evidence from

(Dean et al., 2019. Good evidence exists to support the use of N-acetylcysteine as an adjunct

treatment to reduce the total and negative symptoms of schizophrenia. N-acetylcysteine also

appears to be effective in reducing craving in substance use disorders, especially for the

treatment of cocaine and cannabis use among young people, in addition to preventing relapse in

already abstinent individuals. Effects of N-acetylcysteine on obsessive-compulsive and related

disorders, as well as on mood disorders, remain unclear with mixed reviews, even though

promising evidence does exist. Larger and better-designed studies are required to further

investigate the clinical effectiveness of N-acetylcysteine in these areas. Oral N-acetylcysteine is

safe and well tolerated without any considerable adverse effects. Current evidence supports its

use as an adjunctive therapy clinically for psychiatric conditions, administered concomitantly

PSYCHIATRIC MENTAL HEALTH NURSE PRACTITIONER

References:

1-7. doi:10.3109/13668250.2017.1413079Top of FormBottom of Form